Literature DB >> 16921112

Interleukin-6 gene polymorphism confers susceptibility to pulmonary hypertension in chronic obstructive pulmonary disease.

Saadia Eddahibi1, Ari Chaouat, Li Tu, Christos Chouaid, Emmanuel Weitzenblum, Bruno Housset, Bernard Maitre, Serge Adnot.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16921112     DOI： 10.1513/pats.200603-038MS

Source DB:  PubMed          Journal:  Proc Am Thorac Soc        ISSN： 1546-3222


× No keyword cloud information.
  22 in total

1.  Emergence of fibroblasts with a proinflammatory epigenetically altered phenotype in severe hypoxic pulmonary hypertension.

Authors:  Min Li; Suzette R Riddle; Maria G Frid; Karim C El Kasmi; Timothy A McKinsey; Ronald J Sokol; Derek Strassheim; Barbara Meyrick; Michael E Yeager; Amanda R Flockton; B Alexandre McKeon; Douglas D Lemon; Todd R Horn; Adil Anwar; Carlos Barajas; Kurt R Stenmark
Journal:  J Immunol       Date:  2011-08-03       Impact factor: 5.422

2.  The genomic complexity underlying pulmonary arterial hypertension: from mendel to networks.

Authors:  Revathi Rajkumar; Ferhaan Ahmad
Journal:  Am J Respir Crit Care Med       Date:  2014-05-15       Impact factor: 21.405

3.  -174G/C polymorphism in the interleukin-6 promoter is differently associated with prostate cancer incidence depending on race.

Authors:  S Mandal; F Abebe; J Chaudhary
Journal:  Genet Mol Res       Date:  2014-01-10

Review 4.  gp130 at the nexus of inflammation, autoimmunity, and cancer.

Authors:  J S Silver; C A Hunter
Journal:  J Leukoc Biol       Date:  2010-07-07       Impact factor: 4.962

5.  Cigarette smoke exposure up-regulates endothelin receptor B in human pulmonary artery endothelial cells: molecular and functional consequences.

Authors:  J Milara; J L Ortiz; G Juan; R Guijarro; P Almudever; M Martorell; E J Morcillo; J Cortijo
Journal:  Br J Pharmacol       Date:  2010-12       Impact factor: 8.739

6.  Circulating endotoxin and interleukin-6 levels are associated with Doppler-evaluated pulmonary vascular resistance in cirrhotic patients.

Authors:  Georgios N Kalambokis; Athanasia Mouzaki; Maria Rodi; Konstantinos Pappas; Panagiotis Korantzopoulos; Epameinondas V Tsianos
Journal:  Hepatol Int       Date:  2012-02-02       Impact factor: 6.047

7.  Prostacyclin inhibits IFN-gamma-stimulated cytokine expression by reduced recruitment of CBP/p300 to STAT1 in a SOCS-1-independent manner.

Authors:  Derek Strassheim; Suzzette R Riddle; Danielle L Burke; Mark W Geraci; Kurt R Stenmark
Journal:  J Immunol       Date:  2009-11-13       Impact factor: 5.422

Review 8.  Cellular and molecular basis of pulmonary arterial hypertension.

Authors:  Nicholas W Morrell; Serge Adnot; Stephen L Archer; Jocelyn Dupuis; Peter Lloyd Jones; Margaret R MacLean; Ivan F McMurtry; Kurt R Stenmark; Patricia A Thistlethwaite; Norbert Weissmann; Jason X-J Yuan; E Kenneth Weir
Journal:  J Am Coll Cardiol       Date:  2009-06-30       Impact factor: 24.094

9.  Genetic influences on right ventricular systolic pressure (RVSP) in chronic obstructive pulmonary disease (COPD).

Authors:  Janet G Shaw; Annette G Dent; Linda H Passmore; Darryl J Burstow; Rayleen V Bowman; Paul V Zimmerman; Kwun M Fong; Ian A Yang
Journal:  BMC Pulm Med       Date:  2012-06-13       Impact factor: 3.317

10.  TIFA protein expression is associated with pulmonary arterial hypertension.

Authors:  Hao-Chih Chang; Tong-You Wade Wei; Pei-Yu Wu; Ming-Daw Tsai; Wen-Chung Yu; Chen-Huan Chen; Shih-Hsien Sung
Journal:  Sci Rep       Date:  2021-07-08       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.